Researchers at the University of Wisconsin-Madison have developed a wearable device that can non-invasively measure tendon tension when wearers are engaged in physical activity. The technology could help researchers to measure and understand the forces that act on muscles during movement. These data are useful for scientists designing treatments an (Read more...)
Terumo is launching in Europe its RelayPro Thoracic Stent-Graft System, initially being released to a limited set of institutions with wider availability expected soon. The device is designed to allow patients with narrower access vessels to benefit from thoracic endovascular aortic repair (TEVAR) procedures. It’s based on the previously (Read more...)
Shire’s board may recommend its shareholders accept a bid from the Japanese-based pharmaceutical company Takeda, Shire announced in a press release.
The proposal includes 21.75 pounds in cash and 27.26 pounds in new Takeda shares per Shire share, for a total of approximately 46 billion pounds, the release said.
Shire’s board “would be willing to recommend the revised proposal,” contingent on a resolution of other terms of the offer including an agreement of certain terms, completion of a confirmatory due diligence review, the unanimous and unconditional recommendation of
CheckedUp has entered a content licensing agreement with the American Academy of Ophthalmology to provide professional programing on its waiting room and exam room technology platforms, the company announced in a press release.CheckedUp provides specia…
WASHINGTON ― At the American Society of Cataract and Refractive Surgery meeting, Allen Ho, MD, of Wills Eye Hospital, discusses data gleaned from the AAO’s IRIS Registry showing that the earlier wet age-related macular degeneration is detected and treated with anti-VEGF agents, the better the patient’s vision will be over time.
HEIDELBERG, Germany–(BUSINESS WIRE)–Novaliq GmbH, een gespecialiseerd farmaceutisch bedrijf met een revolutionair platform voor medicijntoediening dat slecht oplosbare geneesmiddelen verandert in effectieve oogheelkundige therapieën heeft vandaag aangekondigd dat vier wetenschappelijke posters zullen worden gepresenteerd op de bijeenkomst van de Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaïi (29 april- 3 mei). De verscheidenheid aan te presenteren gegevens wee